SEC ownership of Septerna, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001984086.

Comparable stake leader

Third Rock Ventures V, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

50/50

Latest evidence

31 Mar 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Third Rock Ventures V, L.P.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
31 Mar 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001984086
Issuer location
South San Francisco, CA

Ownership snapshot

Top shareholders of Septerna, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Third Rock Ventures V, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
50/50
Latest evidence
31 Mar 2026
3/4/5 13D/G 13F Lead comparable stake: 14% 13D/G row: Third Rock Ventures V, L.P. Showing 1-8 of 50 holder rows.

Quick read

Third Rock Ventures V, L.P. leads the comparable SEC ownership view at 14%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Third Rock Ventures V, L.P.'s linked filing trail.
Comparable ownership Top 5
Third Rock Ventures V, L.P. 14%
DRIEHAUS CAPITAL MANAGEMENT LLC 10%
BIOTECHNOLOGY VALUE FUND L P 3.8%
RA CAPITAL MANAGEMENT, L.P. 15%
TRV GP V, LLC 14%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Third Rock Ventures V, L.P.
3/4/5 13D/G
10%+ Owner
14%
from 13D/G
$54,803,075
9,368,047 shares
28 Oct 2024
DRIEHAUS CAPITAL MANAGEMENT LLC
13F 13D/G
Company
10%
from 13D/G
$105,625,595
4,395,572 shares
31 Mar 2026
BIOTECHNOLOGY VALUE FUND L P
13D/G
BVF PARTNERS L P/IL
3.8%
$42,813,056
1,720,782 shares
-$66,562,509 31 Dec 2025
RA CAPITAL MANAGEMENT, L.P.
13F 3/4/5
Company · Director, 10%+ Owner
15%
$168,110,468
6,995,858 shares
31 Mar 2026
TRV GP V, LLC
13F
Company
13F
14%
$149,360,652
6,215,591 shares
31 Mar 2026
TRV GP VI, LLC
13F
Company
13F
9.3%
$101,206,166
4,211,659 shares
31 Mar 2026
Samsara BioCapital, LLC
13F
Company
13F
7%
$75,673,546
3,149,128 shares
31 Mar 2026
GOLDMAN SACHS GROUP INC
13F
Company
13F
6.4%
$69,841,441
2,906,427 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$3,725,560.

Buys
$0
Insiders: 0
Sells
$3,725,560
Insiders: 3
Net
-$3,725,560
Shares: -126,448
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 126,448
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 48,494 $0 $1,566,638 -$1,566,638
3-6 0 74,453 $0 $2,095,699 -$2,095,699
6-9 0 3,501 $0 $63,223 -$63,223
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 23 reporting-owner rows connected to Septerna, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
23
Largest Forms 3/4/5 holder
Third Rock Ventures VI, L.P.
Net 12M change
-$3,725,560
Latest report
01 Jul 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Third Rock Ventures VI, L.P. 10%+ Owner $62,553,072 Mixed 24 Feb 2025
Third Rock Ventures V, L.P. 10%+ Owner $54,803,075 Mixed 28 Oct 2024
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner $8,610,867 Mixed 26 Jun 2026
Elizabeth Bhatt President and COO $4,505,445 -$213,204 -4.5% Filing P/S 15 Apr 2026
Daniel D. Long SVP, Drug Discovery $3,356,497 -$710,333 -17% Filing P/S 01 Jul 2026
Jeffrey Finer Chief Executive Officer, Director $2,282,263 Mixed 06 Feb 2026
Uwe Klein SVP, Biological Sciences $1,477,880 Mixed 06 Feb 2026
Alan Ezekowitz Director $813,451 Filing P/S 26 Jun 2026
Ran Xiao Interim CFO $339,704 Mixed 24 Oct 2024
Gil M. Labrucherie Chief Financial Officer $234,000 Filing P/S 06 Feb 2026
Samira Shaikhly Chief People Officer $27,897 -$2,802,023 -99% Filing P/S 29 Jun 2026
Shalini Sharp Director Mixed 26 Jun 2026
Jake Simson Director Mixed 26 Jun 2026
Jeffrey K. Tong Director Mixed 26 Jun 2026
Abraham Bassan Director Mixed 26 Jun 2026
Bernard Coulie Director Mixed 26 Jun 2026
Keith Michael Gottesdiener Director Mixed 26 Jun 2026
Mark A. Wilson Chief Legal Officer Mixed 06 Feb 2026
RA Capital Healthcare Fund LP Director, 10%+ Owner Mixed 26 Jun 2026
RA Capital Nexus Fund III, L.P. Director Mixed 26 Jun 2026

Recent insider transactions for Septerna, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Daniel D. Long SEPN Common Stock Sale -3.34% $114,528 $34.36 -3,333 96,412 01 Jul 2026 Direct
Daniel D. Long SEPN Common Stock Options Exercise 3.46% 3,333 99,745 01 Jul 2026 Direct
Daniel D. Long SEPN Stock Option (Right to Buy) Options Exercise -32.1% -3,333 7,043 01 Jul 2026 Direct
Samira Shaikhly SEPN Common Stock Sale -73.3% $76,622 $35.18 -2,178 793 29 Jun 2026 Direct
Samira Shaikhly SEPN Common Stock Options Exercise 274.6% 2,178 2,971 29 Jun 2026 Direct
Samira Shaikhly SEPN Stock Option (Right to Buy) Options Exercise -9.45% -2,178 20,865 29 Jun 2026 Direct
RA CAPITAL MANAGEMENT, L.P. SEPN Stock Option (Right to Buy) Award 15,000 15,000 26 Jun 2026 See Footnotes
RA CAPITAL MANAGEMENT, L.P. SEPN Stock Option (Right to Buy) Award 15,000 15,000 26 Jun 2026 See Footnotes
Ra Capital Management, L.P. SEPN Stock Option (Right to Buy) Award 15,000 15,000 26 Jun 2026 See Footnotes
Ra Capital Management, L.P. SEPN Stock Option (Right to Buy) Award 15,000 15,000 26 Jun 2026 See Footnotes
Ra Capital Management, L.P. SEPN Stock Option (Right to Buy) Award 15,000 15,000 26 Jun 2026 See Footnotes
Abraham Bassan SEPN Stock Option (Right to Buy) Award 15,000 15,000 26 Jun 2026 Direct
Shalini Sharp SEPN Stock Option (Right to Buy) Award 15,000 15,000 26 Jun 2026 Direct
Bernard Coulie SEPN Stock Option (Right to Buy) Award 15,000 15,000 26 Jun 2026 Direct
Jeffrey K. Tong SEPN Stock Option (Right to Buy) Award 15,000 15,000 26 Jun 2026 Direct
Keith Michael Gottesdiener SEPN Stock Option (Right to Buy) Award 11,260 11,260 26 Jun 2026 Direct
Alan Ezekowitz SEPN Stock Option (Right to Buy) Award 15,000 15,000 26 Jun 2026 Direct
Jake Simson SEPN Stock Option (Right to Buy) Award 15,000 15,000 26 Jun 2026 Direct
Daniel D. Long SEPN Common Stock Sale -13.5% $532,582 $35.51 -15,000 96,412 22 Jun 2026 Direct
Daniel D. Long SEPN Common Stock Options Exercise 15.6% 15,000 111,412 22 Jun 2026 Direct
Daniel D. Long SEPN Stock Option (Right to Buy) Options Exercise -59.1% -15,000 10,376 22 Jun 2026 Direct
Samira Shaikhly SEPN Common Stock Sale -88.7% $219,224 $35.08 -6,250 793 12 Jun 2026 Direct
Samira Shaikhly SEPN Common Stock Options Exercise 788.2% 6,250 7,043 12 Jun 2026 Direct
Samira Shaikhly SEPN Stock Option (Right to Buy) Options Exercise -20.8% -6,250 23,750 12 Jun 2026 Direct
Samira Shaikhly SEPN Common Stock Sale -88.2% $171,682 $28.93 -5,935 793 01 Jun 2026 Direct
Samira Shaikhly SEPN Common Stock Options Exercise 748.4% 5,935 6,728 01 Jun 2026 Direct
Samira Shaikhly SEPN Stock Option (Right to Buy) Options Exercise -70.2% -5,935 2,517 01 Jun 2026 Direct
Samira Shaikhly SEPN Common Stock Sale -93.7% $354,656 $30.06 -11,798 793 26 May 2026 Direct
Samira Shaikhly SEPN Common Stock Options Exercise 1487.8% 11,798 12,591 26 May 2026 Direct
Samira Shaikhly SEPN Stock Option (Right to Buy) Options Exercise -33.9% -11,798 23,043 26 May 2026 Direct
Elizabeth Bhatt SEPN Common Stock Sale -2.24% $97,343 $24.34 -4,000 174,209 15 Apr 2026 Direct
Elizabeth Bhatt SEPN Common Stock Options Exercise 2.3% 4,000 178,209 15 Apr 2026 Direct
Elizabeth Bhatt SEPN Stock Option (Right to Buy) Options Exercise -4.5% -4,000 84,911 15 Apr 2026 Direct
Samira Shaikhly SEPN Common Stock Sale -98.9% $1,979,838 $28.10 -70,453 793 02 Mar 2026 Direct
Samira Shaikhly SEPN Common Stock Options Exercise 8884.4% 70,453 71,246 02 Mar 2026 Direct
Samira Shaikhly SEPN Stock Option (Right to Buy) Options Exercise -95.3% -70,453 3,460 02 Mar 2026 Direct
Elizabeth Bhatt SEPN Common Stock Sale -2.24% $115,860 $28.97 -4,000 174,209 18 Feb 2026 Direct
Elizabeth Bhatt SEPN Common Stock Options Exercise 2.3% 4,000 178,209 18 Feb 2026 Direct
Elizabeth Bhatt SEPN Stock Option (Right to Buy) Options Exercise -4.31% -4,000 88,911 18 Feb 2026 Direct
Daniel D. Long SEPN Stock Option (Right to Buy) Award 80,000 80,000 06 Feb 2026 Direct
Uwe Klein SEPN Stock Option (Right to Buy) Award 80,000 80,000 06 Feb 2026 Direct
Samira Shaikhly SEPN Stock Option (Right to Buy) Award 80,000 80,000 06 Feb 2026 Direct
Gil M. Labrucherie SEPN Stock Option (Right to Buy) Award 125,000 125,000 06 Feb 2026 Direct
Jae B. Kim SEPN Stock Option (Right to Buy) Award 125,000 125,000 06 Feb 2026 Direct
Elizabeth Bhatt SEPN Stock Option (Right to Buy) Award 155,000 155,000 06 Feb 2026 Direct
Jeffrey Finer SEPN Stock Option (Right to Buy) Award 400,000 400,000 06 Feb 2026 Direct
Mark A. Wilson SEPN Stock Option (Right to Buy) Award 165,000 165,000 06 Feb 2026 Direct
Daniel D. Long SEPN Common Stock Sale -3.63% $63,223 $18.06 -3,501 92,911 10 Nov 2025 Direct
Keith Michael Gottesdiener SEPN Stock Option (Right to Buy) Award 33,246 33,246 25 Sep 2025 Direct
Uwe Klein SEPN Common Stock Options Exercise 23,008 23,008 18 Aug 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .